DatasetName,RRP1B_C(392) RRP1B_C(394) RRP1B_C(395) RRP1B_S(160) RRP1B_S(227) RRP1B_S(245) RRP1B_S(255) RRP1B_S(278) RRP1B_S(350) RRP1B_S(374) RRP1B_S(392) RRP1B_S(394) RRP1B_S(395) RRP1B_S(422) RRP1B_S(434) RRP1B_S(452) RRP1B_S(453) RRP1B_S(458) RRP1B_S(460) RRP1B_S(468) RRP1B_S(495) RRP1B_S(511) RRP1B_S(513) RRP1B_S(561) RRP1B_S(579) RRP1B_S(630) RRP1B_S(640) RRP1B_S(643) RRP1B_S(661) RRP1B_S(680) RRP1B_S(688) RRP1B_S(701) RRP1B_S(702) RRP1B_S(706) RRP1B_S(714) RRP1B_S(717) RRP1B_S(718) RRP1B_S(727) RRP1B_S(731) RRP1B_S(732) RRP1B_S(735) RRP1B_S(736) RRP1B_T(237) RRP1B_T(436) RRP1B_T(454) RRP1B_T(647) RRP1B_T(677) RRP1B_T(699) RRP1B_T(710) RRP1B_T(712) RRP1B_T(728) RRP1B_T(730) RRP1B_T(746) RRP1B_T(747),RRP1B_T(708)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.48653046725748483,
SR2019_MCF7_Biol_repl_3,0.5175789957186164,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5176669988894868,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5105175931239262,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5226168224125625,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,0.5157535959703323,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.5171154381225541,
ZX2022_Control Replicate 2,0.5083152337437029,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5400818534948539,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5146400993903232,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5129682563381242,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.5147593475439595,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5202597462316721,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5168387409667339,
WZ2023_Pu_010_30min,0.520114381092819,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5205053411547447,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.5149494928586004,
FSO2013_Ratio M/L normalized Rep3___3,0.4784501090203491,
AH2018_TMTMS3_1_C,0.5181588914762433,
JJ2018_Ratio H/L normalized___1,0.5245639902896057,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5019216692502092,
AH2018_SILAC_MR_2_N,0.508697168570179,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.518906820549695,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.5300259368647525,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.526081130593653,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5214899268489946,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.515186212332643,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5067547946889774,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5231667945609869,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.5151386448038691,
KBE2022_Log2_Ex_34_U,0.5153284730291031,
WZ2023_Pu_005_10min,0.5197470757874116,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5155882223523683,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.5156012003165901,
WZ2023_Pu_025_30min,0.5161323030708538,
AH2018_SILAC_MR_2_X,0.5145847583285463,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5107300878034997,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.49885534282782545,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5191025264227482,
JJ2018_Ratio M/L normalized pP3,0.50354960930477,
AH2018_SILAC_M_2_N,0.5229848855517782,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.518325700273959,
AH2018_LFQ_1_C,0.519527469388121,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5152898558760629,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5240434951669996,
CK2022_11 40-1,0.515690051514962,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5238393276554557,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5379214290167211,
FSO2013_Ratio H/L normalized Rep2,0.5316767919107852,
WZ2023_Pu_005_20min,0.5205722794754354,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5165129921027277,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5214059188456548,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,0.4976746128658149,
SR2019_BT549_Biol_repl_3,0.517076390723055,
RCJD2014_20min_mean,0.5179232155629815,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5147427827776613,
CK2022_1 200-1,0.5219802252788912,
PG2020_Intensity Mock_10h_D,0.5064848328243914,
SR2019_MCF10A_Biol_repl_2,0.5160845010945039,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.518399660223087,
RCJD2014_5min_1,0.5187035949082252,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,0.5171425112740414,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5002781971845718,
PG2020_Intensity 2h_C,0.5037358537960837,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5082823794816251,
KBE2022_Log2_Ex_8_T,0.5145894956078537,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5187602647552486,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5263494795475713,
CK2022_3 40-1,0.5177359047477955,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5161296123086394,
HH2022_Reporter intensity 8,0.5168579280310545,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,0.5224465720679816,
AH2018_TMTMS3_2_N,0.5180528261724691,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5170034075439573,
YA2020_Reporter_intensity_Normal_No.1,0.5126494676021641,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,0.5100734374455977,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5115542768096194,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5139608343072859,
HS2024_8_I_T3,,
CF2017_EOC 3,0.517679885002032,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,0.5164442584849811,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5198026072051606,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5176107632004547,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.511222880269102,
KS2014_Intensity N3,0.5401607941190896,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5227443696726681,
FSO2013_Ratio H/M normalized Rep2,0.48755020655425757,
RAM2015_Log2 A,0.5240611792073326,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,0.5314098244553926,
CF2017_OSE 27,0.5161685016339953,
KS2014_Intensity E15_2,0.5450519337002204,
BS2014_Log2(Ratio H/L protein),0.5478431887673992,
PG2020_Intensity 8h_A,0.5088139054082279,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.5155066754241201,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5199858830683817,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5156225453406109,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5165709128606462,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.515272911917676,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5167244814861844,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5220312405748645,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5121424284942014,
FSO2013_Ratio M/L normalized Rep2,0.5075652488359177,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.517449665626847,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5172190603082863,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5101219230056896,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5139534475213515,
DL2023_control-1,0.5172534497104633,
AR2021_ALG 10 μM,0.5368877250386057,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5187569061780629,
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5154004939400686,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5171873332827709,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5161104354289554,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5227926134617368,
JW2021_After_3,,
GF2025_P8_Sph,0.5151568521374061,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5274938042921672,
AH2018_SILAC_2_N,0.5227110953574562,
CK2022_11 200-1,0.5161370242738555,
CK2022_12 200-1,0.5163497422651019,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5165816119075126,
WZ2023_Su_010_20min,0.5186683186453107,
AH2018_TMTMS2_2_N,0.5199496834146248,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5137290563558443,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5174178909017763,
KS2014_Intensity N4,0.5446242090902578,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.5167481810556064,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5186982174971191,
CK2022_14 200-1,0.5207063906359987,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5166229600120458,
AST2020_anti-CD3+PDL2.2,0.5151474788286655,
PG2020_Intensity Mock_10h_A,0.5013736818559489,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5141330820807921,
GF2025_P1_Adh,0.5155413856469967,
GF2025_P1_Sph,0.5160503460863395,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5261615648112782,
CF2017_EOC 1,0.516170088797429,
CK2022_3 200-1,0.5220739120995698,
AH2018_LFQ_IT_3_C,0.5249866446760975,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,0.5110635504186449,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5315902329647262,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5080481617071873,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.5168067971866847,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5175043716506229,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5219272170567025,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.510880464235622,
AR2021_ALG 1 μM,0.5231576035815863,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.526636938354266,
CR2017_Ratio Replicate 3.2,0.5090333714657026,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5182431696027167,
CK2022_9 16-1,0.5136633089089458,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,0.5182742232196619,
CK2022_13 200-1,0.5203650568732724,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5091154207352803,
CK2022_16 16-1,0.5140009524886776,
FS2019_db/db3,,
CK2022_15 40-1,0.5171246631413523,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),0.5312951848378048,
WZ2023_Su_005_10min,0.5173294046852551,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5145011425492979,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5238170057677581,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5187149295469181,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5150178493966682,
AH2018_LFQ_M_1_N,0.5166312758688569,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5235587631366421,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5140902882626779,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5018416697787244,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5148880280377626,
RN2012_L13,0.5186323318577927,
LG2023_Control-1_intensity,0.5150791708508085,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.514461166776208,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5141212270984111,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5157582122998994,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5090819117149386,
HH2022_Reporter intensity 6,0.5184206582460731,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,0.5180765773031085,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5177184031963854,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5164756682387571,
GF2025_P3_Adh,0.5162182027187115,
SR2019_JIMT1_Biol_repl_2,0.5158537711372041,
AH2018_TMTMS2_1_C,0.5209638015647295,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5112264642180325,
KBE2022_Log2_Ex_19_U,0.5152478208276958,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.5097650749188036,
YA2020_Reporter_intensity_Cancer_No.1,0.5151858513386499,
AST2020_Control,0.5140613109106574,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5128279612721296,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5176269756756788,
LG2023_Control-2_intensity,0.51893267238728,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,0.5179387182950626,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5140838648819054,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5167929227973709,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5061100640190384,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5406786580625209,
HH2022_Reporter intensity 1,0.5162186201075274,
HH2022_Reporter intensity 2,0.5164610173737593,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5142915942587724,
SR2019_MCF7_Biol_repl_1,0.5167822109264336,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5197894690037825,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.524996631119564,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.507907740944358,
AR2021_KD 72h,0.5279181154064034,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.519328267296399,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.5178807673828255,
KBE2022_Log2_Ex_13_T,0.5148185922388354,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5022470374813752,
CF2017_OSE 29,0.5178254545434994,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.5168670247751495,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5133981850113698,
RN2012_L12,0.515616489575198,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5188864886764433,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5160821051614319,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.5306317610190748,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5161286716682587,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5153853648523931,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5011806810880466,
FSO2013_Ratio H/M normalized Rep2___2,0.49825778735844317,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.512813504501858,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5418267097547128,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5163978378469486,
CK2022_5 200-1,0.5166498304013297,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5169727033603039,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.521024110951785,
AH2018_SILAC_MR_1_X,0.5157165337086761,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.514385460989982,
AH2018_SILAC_3_C,0.5185591171746821,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.49541022342006014,
CK2022_4 16-1,0.5133687016088503,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,0.517179714293968,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.516544977300716,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5164491524998,
JJ2018_Ratio M/L normalized pP2,0.5275124606818399,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5048299521673566,
FSO2013_Ratio H/L normalized Rep3,0.5294020674968065,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.5268746386250173,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.5191725488946295,
AH2018_SILAC_IT_1_X,0.5240426092680661,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5144569173480361,
WZ2023_Pe_025_20min,0.5209359391685376,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5206256796295704,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5182302283996466,
RN2012_H06,0.5156804071054452,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5227361722842012,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,0.5142909737774336,
SR2019_JIMT1_Biol_repl_3,0.5162680638912784,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.51843572867091,
WZ2023_Su_025_10min,0.5201007764715911,
AH2018_LFQ_IT_4_X,0.5186411885040751,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5190038308202941,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.519202160735992,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.5153619878836776,
EP2017_Pervanadate R#1 log2 ratio,0.5238517624845894,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5537413500295213,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.506687535294037,
LY2019_P7+,0.5167563059301503,
EP2017_Untreated R#1 normalized log2 ratio,0.5152912106240191,
RN2012_L10,0.516802580995436,
PG2020_Intensity 4h_C,0.499371427999079,
EP2017_Mitotic R#3 normalized log2 ratio,0.5187021614692453,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5134758220148634,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5221923310737702,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5313982302989538,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5151922415314769,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.532074452949667,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5203693781626826,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5205833826732402,
GF2025_P9_Sph,0.5147584683167694,
CK2022_6 200-1,0.5168510628143989,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5202767432302792,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.5165586040129857,
PG2020_Intensity 2h_D,0.49529950930490646,
EP2017_Untreated R#3 normalized log2 ratio,0.5163598475349848,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5162421523519399,
KS2014_Intensity pY_C4,0.5149278262135112,
CR2017_Ratio Replicate 3.5,0.49816083390577337,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5065676689640247,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5203873975844926,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5250249781706603,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5144901892029766,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5191763757644551,
PG2020_Intensity CT_C,0.50349931304182,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5149888394213953,
EP2017_Untreated R#3 log2 ratio,0.5162127596246556,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.49940822331486595,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5159221636899288,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5009132976952541,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5161384150481022,
YA2020_Reporter_intensity_Normal_No.2,0.5128337669807379,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5419077969602741,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,0.495899443543458,
AH2018_LFQ_M_2_N,0.5253845173099138,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5150395941506494,
CK2022_2 16-1,0.5137171958398331,
RAM2015_Log2 B,0.5188253031894969,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.5318502436761571,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5228418253498601,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,0.5161406678307328,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5054798741624316,
WZ2023_Su_025_30min,0.5204491855519953,
AH2018_LFQ_4_N,0.5160297220074562,
CR2017_Ratio Replicate 1.2,0.5133687086100309,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5174704429186741,
AH2018_SILAC_M_1_X,0.5224698354636891,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.517097182230109,
LY2019_P6+,0.5137152953823567,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5197456434509212,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5166927487677638,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5518324208324915,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5189506773493734,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,0.5163898108781504,
AH2018_LFQ_M_4_N,0.5211432880512794,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5009432500705052,
AH2018_LFQ_2_X,0.5175016267934124,
PG2020_Intensity 2h_B,0.5091033550375575,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5419307124183574,
GF2025_P3_Sph,0.5161390785983454,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5225982699685732,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5106290982332806,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5203168311441014,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5152948315470504,
CR2017_Ratio Replicate 2.4,0.5018688746350832,
ZQ2022_N1,,
LY2019_P6-,0.5170195821743168,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5210614798960904,
AH2018_LFQ_3_N,0.5180243134097257,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5159794820630855,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5146962958821159,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5128721064717223,
CK2022_7 40-1,0.5161300855428547,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5030271713384802,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5242258960645078,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5201365933669904,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5119955037594832,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5166620210509257,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5169971674026194,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5164441554480201,
PG2020_Intensity 10h_D,0.5147061962172704,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5213650225000256,
FSO2013_Ratio M/L normalized Rep1___3,0.5310877046802032,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5058976290229887,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5128204631901185,
AH2018_LFQ_M_4_C,0.5172765618045058,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.5168941853396133,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5191453420049904,
CK2022_6 40-1,0.5162325186894784,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5149338421445603,
LY2019_P3-,0.5125561825130512,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5249966015102945,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.5155179701650789,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5095716245501092,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5227451596342262,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5180481394569708,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,0.49442744742711436,
AH2018_TMTMS2_2_C,0.5221242813000961,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5185434606658564,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5248180063614154,
LY2019_P8+,0.5160059339046476,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.5157685515876467,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,0.5160938462992706,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.517408048307836,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5069169973609275,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,0.5150755769524169,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5148770629744495,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.517988382960681,
LY2019_P2-,0.5160605523838973,
AH2018_LFQ_IT_1_X,0.5224863697152142,
JJ2018_Ratio H/L normalized pP3___1,0.512774392039093,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5254346691933335,
AST2020_Control.2,0.5146459791388696,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5224389892373522,
FSO2013_Ratio H/L normalized Rep2___3,0.5244016266537099,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5176230697924948,
SR2019_MCF10A_Biol_repl_4,0.5173388882015147,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5152238040557601,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,0.5040084593828031,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.5183881961690459,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5168626259494199,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5113651223090001,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5201670794325045,
KS2014_Intensity C2,0.5476350146546382,
FSO2013_Ratio H/L normalized Rep1___2,0.5150861852617429,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5147215094242105,
CK2022_9 200-1,0.5158554290486587,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5158360234467002,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5165863784582,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.49657566515103135,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5442497063302975,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.514880687166487,
FSO2013_Ratio H/M normalized Rep3___2,0.5151296367353831,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5151841704268142,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5191732113827268,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5413941516224012,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.522172228029448,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5228291970180533,
AH2018_SILAC_MR_2_C,0.5122039712585374,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5143195262750231,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5152703478685099,
JJ2018_Ratio H/M normalized___1,0.5110318604715145,
RCJD2014_15min_2,0.5094243299290964,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5181082716022378,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5294351504067164,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.5141582416776479,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5232334233172611,
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.522000445567076,
AH2018_LFQ_IT_4_N,0.5169117498374995,
CK2022_15 200-1,0.5203362641241417,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5100942819137666,
JJ2018_Ratio M/L normalized pP3___1,0.503385755453033,
KBE2022_Log2_Ex_34_T,0.5149692513119143,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5161744895181984,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5217883575619532,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5220607508692522,
RN2012_H01,0.5188514256511453,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,0.5140315441464645,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5239349346399748,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5146981686199327,
KBE2022_Log2_Ex_44_U,0.5132046716932774,
WZ2023_Pe_010_20min,0.5249437577683301,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5267754520724458,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5157714223073314,
KS2014_Intensity C1,0.5447637147237494,
FSO2013_Ratio H/M normalized Rep3___1,0.5105547753807917,
AH2018_SILAC_M_3_C,0.5194914992062503,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5252649310415562,
AH2018_SILAC_M_2_X,0.5230566384106405,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5155798499747211,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5201713533365568,
PG2020_Intensity 6h_C,0.5094838781947431,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.5153425673084848,
AH2018_LFQ_M_3_N,0.5222958831247487,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.519924935198052,
CK2022_15 16-1,0.5138981904663213,
CK2022_3 16-1,0.5145723619427219,
LY2019_P4-,0.519152504555087,
FSO2013_Ratio H/L normalized Rep3___2,0.5294136382956304,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5198954440294079,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.514904132350268,
CK2022_10 16-1,0.5138147455710407,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5098609836901825,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.517229465112633,
AR2021_L41 10 μM,0.49000129017951516,
CF2017_EOC 2,0.5143983220672704,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5227288022683546,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.5110558440046246,
ZX2022_CB treated Replicate 1,0.5092394004109246,
BS2014_Log2(Ratio H/L normalized Rep_3),0.5164738696702932,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5163754893458282,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5185592949387401,
AR2021_L41 1 μM,0.5028950602591129,
JJ2018_Ratio H/M normalized pP1___2,0.5088010510708452,
AH2018_TMTMS2_1_N,0.5187530762150472,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5077562876706404,
KS2014_Intensity C4,0.5471268214296389,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5169472809673845,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,0.4846783724301639,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5243389549277402,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5141928537253938,
FSO2013_Ratio H/M normalized Rep2___3,0.4839296223661859,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5215608966577507,
WZ2023_Pu_025_10min,0.518697571245568,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5214784216336551,
FSO2013_Ratio M/L normalized Rep3___1,0.5110176146007759,
SR2019_JIMT1_Biol_repl_4,0.5164649880474931,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5104725540586391,
JJ2018_Ratio H/L normalized pP1___1,0.5038584631159467,
WZ2023_Pe_010_30min,0.5256547286564065,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5226819678600103,
KS2014_Intensity C6,0.5467310183614517,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5161990554825405,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5109770985664903,
JJ2018_Ratio H/M normalized pP1,0.5029468004069549,
CK2022_16 40-1,0.5173480208658451,
AH2018_SILAC_IT_2_C,0.5201915008481368,
CK2022_5 40-1,0.5162643027923766,
AH2018_LFQ_3_X,0.5158880276372338,
UK2020_UA_3,,
LY2019_P7-,0.5142336519602159,
GF2025_P5_Adh,0.5152422020233606,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5139685766264019,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5119290301121445,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5124209733355735,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5118570849900761,
PG2020_Intensity CT_B,0.5096543375945877,
JJ2018_Ratio M/L normalized___2,0.5100690616866181,
AH2018_SILAC_MR_1_N,0.5134684981938382,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.525224923013574,
AH2018_LFQ_3_C,0.5174358676790571,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5215493694305091,
YA2020_Reporter_intensity_Cancer_No.4,0.5163540839550128,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,0.5115207496032846,
GF2025_P4_Sph,0.5153190579638901,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.514723440366608,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5280773739821705,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5144066916959069,
AST2020_anti-CD3+PDL2,0.5145911850167025,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5147533894527505,
KS2014_Intensity pY_N1,0.5181034578281439,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.4991751723282305,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5084825060785063,
AH2018_TMTMS2_1_X,0.517263651122667,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.516990357056063,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5239035453708006,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,0.5163956275152186,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5179439969438671,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.52248707671413,
PG2020_Intensity 10h_B,0.5122136616816644,
AH2018_TMTMS3_1_X,0.5175005683547859,
CF2017_FTE 14,0.5168574848053463,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5040384847977332,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.5150682906785472,
EP2017_Untreated R#2 normalized log2 ratio,0.5199153629867125,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5191146035704421,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.520186676376285,
AS2011_Ratio H/L Normalized RNAi_2_1,,
